Identification of a novel storage glycine-rich peptide from guava ( Psidium guajava) seeds with activity against Gram-negative bacteria
Bacterial pathogens cause an expressive negative impact worldwide on human health, with ever increasing treatment costs. A significant rise in resistance to commercial antibiotics has been observed in pathogenic bacteria responsible for urinary and gastro-intestinal infections. Towards the developme...
Saved in:
Published in: | Peptides (New York, N.Y. : 1980) Vol. 29; no. 8; pp. 1271 - 1279 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York, NY
Elsevier Inc
01-08-2008
Elsevier Science |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Bacterial pathogens cause an expressive negative impact worldwide on human health, with ever increasing treatment costs. A significant rise in resistance to commercial antibiotics has been observed in pathogenic bacteria responsible for urinary and gastro-intestinal infections. Towards the development of novel approaches to control such common infections, a number of defense peptides with antibacterial activities have been characterized. In this report, the peptide
Pg-AMP1 was isolated from guava seeds (
Psidium guajava) and purified using a Red-Sepharose Cl-6B affinity column followed by a reversed-phase HPLC (Vydac C18-TP).
Pg-AMP1 showed no inhibitory activity against fungi, but resulted in a clear growth reduction in
Klebsiella sp. and
Proteus sp., which are the principal pathogens involved in urinary and gastro-intestinal hospital infections. SDS-PAGE and mass spectrometry (MALDI-ToF) characterized
Pg-AMP1 a monomer with a molecular mass of 6029.34
Da and small quantities of a homodimer. Amino acid sequencing revealed clear identity to the plant glycine-rich protein family, with
Pg-AMP1 the first such protein with activity towards Gram-negative bacteria. Furthermore,
Pg-AMP1 showed a 3D structural homology to an enterotoxin from
Escherichia coli, and other antibacterial proteins, revealing that it might act by formation of a dimer.
Pg-AMP1 shows potential, in a near future, to contribute to development of novel antibiotics from natural sources. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0196-9781 1873-5169 |
DOI: | 10.1016/j.peptides.2008.03.013 |